Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary therapy of acute angle-block glaucoma].

G Strasser, P Kramsall

    Klinische Monatsblatter Fur Augenheilkunde
    |January 1, 1987
    PubMed
    Summary

    In acute angle-closure glaucoma, adding pilocarpine to acetazolamide and timolol therapy was less effective. Omitting pilocarpine significantly improved treatment outcomes for glaucoma patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    High-responsivity operation of quantum cascade detectors at 9 µm.

    Optics express·2022
    Same author

    High-speed interband cascade infrared photodetectors: photo-response saturation by a femtosecond oscillator.

    Optics express·2021
    Same author

    All-optical adaptive control of quantum cascade random lasers.

    Nature communications·2020
    Same author

    Singular charge fluctuations at a magnetic quantum critical point.

    Science (New York, N.Y.)·2020
    Same author

    4.3 μm quantum cascade detector in pixel configuration.

    Optics express·2016
    Same author

    Terahertz Dynamics of a Topologically Protected State: Quantum Hall Effect Plateaus near the Cyclotron Resonance of a Two-Dimensional Electron Gas.

    Physical review letters·2015

    Area of Science:

    • Ophthalmology
    • Glaucoma Research
    • Pharmacological Interventions

    Context:

    • Acute angle-closure glaucoma (AACG) is a medical emergency requiring prompt intraocular pressure (IOP) reduction.
    • Current therapeutic strategies often involve a combination of medications to manage AACG.
    • The role of specific pharmacological agents, like pilocarpine, in combination therapy for AACG warrants further investigation.

    Purpose:

    • To evaluate the comparative efficacy of two primary therapeutic regimens in managing acute angle-closure glaucoma.
    • To determine if the addition of pilocarpine to acetazolamide and timolol offers additional benefit or detriment in AACG treatment.

    Summary:

    • A retrospective study analyzed 94 eyes with acute angle-closure glaucoma.
    • Sixty-eight eyes received acetazolamide, timolol, and pilocarpine.
    • Twenty-six eyes were treated with acetazolamide and timolol alone, demonstrating significantly better outcomes.

    Impact:

    • Findings suggest that pilocarpine may not be essential and could potentially reduce the effectiveness of glaucoma treatment.
    • This research could influence clinical guidelines for AACG management, potentially simplifying treatment regimens.
    • Highlights the importance of evaluating each component of combination therapy for ocular conditions.

    Related Experiment Videos